JASiMA–JAVLOR® Switch in Maintenance Phase II study assessing the feasibility of maintenance treatment with Vinflunine after first line therapy with Gemcitabine and Cisplatin in patients with advanced or metastatic urothelial cancer
Laufzeit: 01.01.2011 - 31.12.2013